UK Markets closed

AstraZeneca Is Committed to Business in China, Says CEO

Nov.05 -- AstraZeneca is doubling down on its second largest market, China, as it teams up with one of China's largest investment banks on a $1 billion healthcare fund. AstraZeneca Chief Executive Officer Pascal Soriot tells Bloomberg's Selina Wang in an exclusive interview that the pharma giant is also taking steps to establish centers for drug research and artificial intelligence innovation in Shanghai, along with an import platform to help commercialize drugs -- even potentially for rival companies.